Sharabiany, Sarah http://orcid.org/0000-0003-2222-2037
Blok, Robin D.
Lapid, Oren
Hompes, Roel
Bemelman, Wilhelmus A.
Alberts, Victor P.
Lamme, Bas
Wijsman, Jan H.
Tuynman, Jurriaan B.
Aalbers, Arend G. J.
Beets, Geerard L.
Fabry, Hans F. J.
Cherepanin, Ivan M.
Polat, Fatih
Burger, Jacobus W. A.
Rutten, Harm J. T.
Bosker, Robert J. I.
Talsma, Koen
Rothbarth, Joost
Verhoef, Cees
van de Ven, Anthony W. H.
van der Bilt, Jarmila D. W.
de Graaf, Eelco J. R.
Doornebosch, Pascal G.
Leijtens, Jeroen W. A.
Heemskerk, Jeroen
Singh, Baljit
Chaudhri, Sanjay
Gerhards, Michael F.
Karsten, Tom M.
de Wilt, Johannes H. W.
Bremers, Andre J. A.
Vuylsteke, Ronald J. C. L. M.
Heuff, Gijsbert
van Geloven, Anna A. W.
Tanis, Pieter J.
Musters, Gijsbert D.
Funding for this research was provided by:
KWF Kankerbestrijding (11923)
Article History
Received: 24 December 2019
Accepted: 13 July 2020
First Online: 23 July 2020
Ethics approval and consent to participate
: This protocol has been approved by the by the Medical Ethics Committee AMC, affiliated to the Amsterdam UMC, location AMC. The trial is known under project number 2019_033 and is also registered at “Toetsingonline” (Registration number NL65461.018.18). This study will be conducted according to the principles of Good Clinical Practice. Written informed consent will be obtained from all participating patients prior to inclusion.
: Written permission from each participant is obtained, through the informed consent form, to publish the results in scientific papers.
: The authors declare that they have no competing interests.